Securities Times Online News: Goldman Sachs has raised its target stock price for Boston Scientific to $103 and maintained a buy rating. Recently, several institutions have also adjusted their target stock prices for Boston Scientific. Citigroup has raised its target stock price from $98 to $107, maintaining a buy rating; Wells Fargo has raised its target stock price from $98 to $100, maintaining its overweight rating.